To avoid such side effects, some scholars suggested that the downstream intervention of COX-2 (PG synthetase-PGs-PGs receptor signaling pathway) may be superior to upstream interference of COX-2 in the treatment of acute or chronic brain injury [8]. Here, PTGS2 is linked to brain injury.